Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N; WHO Pathogens Priority List Working Group. Tacconelli E, et al. Among authors: cavaleri m. Lancet Infect Dis. 2018 Mar;18(3):318-327. doi: 10.1016/S1473-3099(17)30753-3. Epub 2017 Dec 21. Lancet Infect Dis. 2018. PMID: 29276051
The global threat of antimicrobial resistance: science for intervention.
Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, Cohen J, Findlay D, Gyssens I, Heuer OE, Kahlmeter G, Kruse H, Laxminarayan R, Liébana E, López-Cerero L, MacGowan A, Martins M, Rodríguez-Baño J, Rolain JM, Segovia C, Sigauque B, Tacconelli E, Wellington E, Vila J. Roca I, et al. Among authors: cavaleri m. New Microbes New Infect. 2015 Apr 16;6:22-9. doi: 10.1016/j.nmni.2015.02.007. eCollection 2015 Jul. New Microbes New Infect. 2015. PMID: 26029375 Free PMC article. Review.
Corrigendum to "The global threat of antimicrobial resistance: science for intervention" [New Microbes New Infect 6 (2015): 22-29].
Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, Cohen J, Findlay D, Gyssens I, Heuer OE, Kahlmeter G, Kruse H, Laxminarayan R, Liébana E, López-Cerero L, MacGowan A, Martins M, Rodríguez-Baño J, Rolain JM, Segovia C, Sigauque B, Tacconelli E, Wellington E, Vila J. Roca I, et al. Among authors: cavaleri m. New Microbes New Infect. 2015 Sep 10;8:175. doi: 10.1016/j.nmni.2015.09.004. eCollection 2015 Nov. New Microbes New Infect. 2015. PMID: 27257501 Free PMC article.
Approaches to demonstration of Ebola virus vaccine efficacy.
Krause PR, Cavaleri M, Coleman G, Gruber MF. Krause PR, et al. Among authors: cavaleri m. Lancet Infect Dis. 2015 Jun;15(6):627-9. doi: 10.1016/S1473-3099(15)00027-4. Epub 2015 May 17. Lancet Infect Dis. 2015. PMID: 26008825 No abstract available.
Use of colistin-containing products within the European Union and European Economic Area (EU/EEA): development of resistance in animals and possible impact on human and animal health.
Catry B, Cavaleri M, Baptiste K, Grave K, Grein K, Holm A, Jukes H, Liebana E, Lopez Navas A, Mackay D, Magiorakos AP, Moreno Romo MA, Moulin G, Muñoz Madero C, Matias Ferreira Pomba MC, Powell M, Pyörälä S, Rantala M, Ružauskas M, Sanders P, Teale C, Threlfall EJ, Törneke K, van Duijkeren E, Torren Edo J. Catry B, et al. Among authors: cavaleri m. Int J Antimicrob Agents. 2015 Sep;46(3):297-306. doi: 10.1016/j.ijantimicag.2015.06.005. Epub 2015 Jun 29. Int J Antimicrob Agents. 2015. PMID: 26215780 Review.
Monoclonal antibodies as anti-infective products: a promising future?
Pelfrene E, Mura M, Cavaleiro Sanches A, Cavaleri M. Pelfrene E, et al. Among authors: cavaleri m. Clin Microbiol Infect. 2019 Jan;25(1):60-64. doi: 10.1016/j.cmi.2018.04.024. Epub 2018 Apr 30. Clin Microbiol Infect. 2019. PMID: 29715552 Free PMC article. Review.
89 results